U.S. Senate to vote this spring on lowering insulin prices – Senator Schumer
U.S. Senate to vote this spring on lowering insulin prices – Senator Schumer
March 22, 2022; 3:31 PM EDT
WASHINGTON, March 22 (Reuters) – U.S. Senate Majority Leader Chuck Schumer said on Tuesday he intends to hold votes this spring on a bill that would cap the cost of insulin, a life-sustaining diabetes drug.
The legislation would place a $35 monthly cap on what patients pay for insulin, Schumer said, and would be paired with another emerging bipartisan plan to drive down the price “in a more comprehensive way, including having the uninsured protected,” Schumer told reporters.
A Type 1 diabetes advocate from the United States shows lower cost insulin bought at a Canadian pharmacy in London, Ontario, Canada June 29, 2019. REUTERS/Carlos Osorio
The Democratic leader added that he is working to place the legislation on the floor of the full Senate following a recess that ends in late April.
Our Standards: The Thomson Reuters Trust Principles.
Reuters source:
